TAU’s Prof. Ilan Tsarfaty Awarded Breast Cancer Research Foundation Grant
Groundbreaking research identifying novel therapeutic targets for the treatment of metastatic breast cancer
Prof. Ilan Tsarfaty of Tel Aviv University's Sackler Faculty of Medicine has been awarded a Breast Cancer Research Foundation (BCRF) grant for his groundbreaking research in identifying novel therapeutic targets for the treatment of metastatic breast cancer.
Prof. Tsarfaty is the first cancer researcher to show that the MET gene is a prognostic factor for breast cancer patients. He has been investigating how the gene promotes metastasis of breast cancer and resistance to therapy, which may lead to the identification of biomarkers of response to therapy and new approaches to preventing the spread of cancer.
Credited to AFTAU Weblog